The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for nitenpyram, a medication aimed at treating New World screwworm infestations in dogs and cats. This marks the first generic animal drug approved for combating the flesh-eating parasite. Nitenpyram tablets are suitable for pets weighing at least two pounds and over four weeks old. While previously approved in 2000 under the brand name Capstar for flea treatment, the FDA emphasized that nitenpyram acts quickly, killing most screwworm larvae within hours. However, it does not provide ongoing protection against new infestations. Recent cases of New World screwworm have been detected in Texas cattle and a dog in New Mexico, highlighting the need for effective treatments against this parasite.
Why It Matters
Nitenpyram’s approval is significant due to the resurgence of New World screwworm, a parasite that historically impacted livestock and wildlife in the U.S. from the 1930s to the 1960s. After being believed eradicated, recent reports of infestations have raised concerns for pet owners and animal health officials. The larvae of the New World screwworm feed on living tissue, posing serious health risks to affected animals. The FDA’s emergency use authorization reflects an urgent response to the current situation, enabling faster access to treatments necessary to combat this harmful parasite.
Want More Context? 🔎
